Given that occludin-deficient mice with experimental stroke exhibited more severe BBB dysfunction, which might lead to increased infarct volume and deteriorated neurological function, we investigated the expression levels of claudin-5 and ZO-1, which are key structural and functional components of the BBB. The gene discussed is CLDN5; the disease is stroke disorder.